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Klinefelter syndrome (KS) is the most common sex chromosome aneuploidy. A distinctive 
characteristic of KS is oligozoospermia. Despite multiple studies that have described the natural 
history of the degenerative process of germ cells in patients with KS, the molecular mechanisms that 
initiate this process are not well characterized. MicroRNA (miRNA)‑mediated post‑transcriptional 
control mechanisms have been increasingly recognized as important regulators of spermatogenesis; 
however, only a few studies have evaluated the role of miRNAs in the gonadal failure of these 
patients. Here, we describe a differential expression profile for the miRNAs in testicular tissue 
samples taken from KS patients. We analysed testicular tissue samples from 4 KS patients and 
5 control patients (obstructive azoospermia) through next‑generation sequencing, which can 
provide information about the mechanisms involved in the degeneration of germ cells. A distinctive 
differential expression profile was identified for 166 miRNAs in the KS patients: 66 were upregulated, 
and 100 were downregulated. An interactome analysis was performed for 7 of the upregulated and the 
20 downregulated miRNAs. The results showed that the target genes are involved in the development, 
proliferation, and differentiation processes of spermatogenesis, which may explain their role in 
the development of infertility. This is the first report of a miRNA expression profile generated from 
testicular tissue samples of KS patients.
Klinefelter syndrome (KS) is the most common sex chromosome aneuploidy in humans, with a prevalence of 
1:500 live  births1. It was first described in 1942 as a syndrome characterized by gynaecomastia, azoospermia, 
and elevated levels of follicle-stimulating hormone (FSH)2. The presence of an extra X chromosome (47,XXY) in 
the standard male chromosome set (46,XY) causes Klinefelter syndrome. Chromosomal nondisjunction during 
meiosis or early embryonic mitosis causes this aneuploidy. Cytogenetic confirmation of aneuploidy is performed 
through conventional karyotype analysis. Approximately 85–90% of KS patients present with a 47,XXY chromo-
some set, while the remaining 10–15% of patients present with mosaicism (47,XXY/46,XY) or aneuploidies with 
more than three sex chromosomes (48,XXXY or 48,XXYY)3,4.
Sexual development in KS patients may be healthy before puberty, showing typical pubertal changes and 
levels of luteinizing hormone (LH), FSH, and  testosterone5. During adolescence, the testicles appear small and 
firm and the patient presents with multiple symptoms of androgen deficiency. Hypogonadotropic hypogonadism 
(HH) is the predominant characteristic, with testosterone levels below 12 nmol/L; low levels of insulin-like 3 
(INSL 3), inhibin B and anti-Müllerian hormone (AMH); and high levels of FSH and  LH6. Infertility is one of 
the distinctive characteristics of KS, found in approximately 10% of azoospermia patients. During puberty, the 
testicles of KS patients grow to a volume of 6 ml; however, although the serum levels of testosterone increase, 
the following features appear: decreasing the number of germ cells, hyaline seminiferous tubules, degenerated 
Sertoli cells, and hyperplasic Leydig  cells7,8.
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Histological analysis of adult testes of KS patients shows abundant seminiferous tubule hyalinization and 
interstitial Leydig cell pseudohyperplasia; some studies also reported findings of Sertoli cell-only  tubules9. 
Although semen analyses of adult KS patients have revealed azoospermia at high frequency, some men with KS 
may have residual spermatogenesis foci; approximately 7.7–8.4% of KS patients produce  spermatozoa10. Unfor-
tunately, natural conception in KS-related infertile couples is very rare; most often, the only hope for biological 
paternity is through testicular sperm extraction (TESE) combined with intracytoplasmic sperm injection (ICSI). 
A meta-analysis of data on surgical sperm retrieval rates showed the presence of spermatozoa in approximately 
40% of the KS patients who underwent  TESE10,11. Nevertheless, the reproductive options for these patients are 
limited and reduced further because the subjacent mechanisms leading to germ cell degeneration are unknown.
Mouse models with a 41,XXY chromosome set show regular germ cell migration and early testis development, 
but germ cell number expansion decreases as development proceeds. Transplantation of XY germ cells in 41,XXY 
testes enables some cells to complete spermatogenesis, suggesting that the primary cause of spermatogenesis 
disruption can be found in germ  cells12.
Spermatogenesis is a strictly regulated process at the transcriptional and post-transcriptional levels leading 
to the continuous production of gametes during adulthood. The post-transcriptional control mechanism medi-
ated by microRNAs (miRNAs) is essential for spermatogenesis  regulation13. miRNAs are small (22 nucleotides), 
nuclear DNA-encoded, non-coding RNA molecules produced in eukaryotic cells. In general, miRNAs silence 
gene expression by targeting mRNA for degradation or by interfering with its  translation14,15; however, few studies 
have investigated the role of miRNAs in the phenotype of patients with  KS16,17.
Transcriptional silencing of genes on X and Y chromosomes occurs in the second half of the pachytene 
phase; however, most of the miRNAs associated with the X chromosome are transcribed and processed at this 
stage. Approximately 86% of the miRNAs located on the X chromosome escape meiotic inactivation during 
 spermatogenesis18. This finding suggests that the levels of these miRNAs may be abnormally high in 47,XXY 
testes, potentially leading to the misregulation of autosomal mRNAs during meiosis and spermatogenesis disrup-
tion in KS patients. This work was based on the hypothesis that the expression profile of miRNAs in the testicular 
tissue of Klinefelter patients differs from that of the controls and at least some of the target genes for differentially 
expressed miRNAs could be involved in spermatogenesis.
Results
Seven (7) testicular samples from 4 Klinefelter syndrome patients and five (5) control testicular samples from 
5 patients with obstructive azoospermia were analysed. The patients’ age range was 33–36 years old. One of the 
patients had a mosaic 47,XXY/46,XY chromosome set (KLI_5 and KLI_6). All the control samples were obtained 
from biopsied tissue of patients with infertility because of azoospermia who were in an age range of 30–40 years. 
All the control patients had a 46,XY karyotype.
Profiling differentially expressed miRNAs
Using a significance threshold of p < 0.05, one hundred and sixty-six (166) hsa-miRNAs with differential expres-
sion in the KS patients and controls were found and were composed of 100 downregulated and 66 upregulated 
miRNA transcripts in the KS sample (Table S1, Supplementary data). Of the 166 miRNAs that showed differential 
expression, 27 belonged to the high-expression level group (i.e., number of sequence counts above the average); 
of these, 20 were downregulated and 7 were upregulated in the KS samples in relation to their expression levels 
in the control group (Table 1 and Fig. 1). The seven (7) upregulated, and the 20 downregulated miRNAs were 
used in separate interactome analyses using the miRNet  database19,20 since they are likely to interfere with gene 
expression of their target genes. The miRNA target prediction was followed by an interactome network analysis 
and a Gene Ontology (GO) enrichment for the following terms: gamete generation, positive regulation of cell 
differentiation, cell morphogenesis involved in differentiation, developmental maturation, cell proliferation, and 
reproductive sexual process. This process produced a group of 39 target genes for the 7 upregulated miRNAs 
(Fig. 2 and Supplementary data Table S2), and 70 target genes for the 20 downregulated miRNAs (Supplementary 
data Figure S1 and Table S3).
The seven (7) upregulated miRNAs were: hsa-miR-125a-5p, hsa-miR-125b-5p, hsa-let-7b-5p, hsa-miR-
199a-5p, hsa-miR-199b-3p, hsa-miR-654-3p, and hsa-miR-127-3p.The target genes of these upregulated miR-
NAs are involved in the following biological processes: cell proliferation (JAG1, PRDM1, CDKN1A, E2F3, EDN1, 
BTG2, E2F7, ERBB2, ERBB3, ETS1, LIF, SMAD4, and AKT1), positive regulation of cell differentiation (ABL1, 
JAG1, PRDM1, EDN1, EZH2, LIN28A, ETS1, LIF, SMAD4, and AKT1), positive regulation of developmen-
tal processes (ABL1, JAG1, PRDM1, CDKN1A, CSNK2A1, EDN1, ITGA3, BTG2, PLXND1, SEMA4C, WNK1, 
EZH2, LIN28A, GPAT4, E2F7, ERBB2, ERBB3, ETS1, HK2, LIF, SMAD4, and AKT1) and reproductive processes 
and gamete generation (PRDM1, EDN1, LIN28A, GPAT4, ETS1, HK2, LIF, AKT1, and SGPL1). Some target 
genes participate in multiple and overlapped biological processes (Supplementary data figure S2). The target 
genes of the 20 downregulated miRNAs (hsa-miR-106b-5p, hsa-miR-30a-3p, hsa-miR-16-5p, hsa-miR-30a-5p, 
hsa-miR-126-3p, hsa-miR-17-5p, hsa-miR-106a-5p, hsa-miR-25-3p, hsa-miR-30c-5p, hsa-let-7g-5p, hsa-miR-
92a-3p, hsa-miR-15b-5p, hsa-miR-103a-3p, hsa-miR-10a-5p, hsa-miR-142-3p, hsa-miR-21-5p, hsa-miR-23b-3p, 
hsa-miR-148b-3p, hsa-miR-93-5p and hsa-miR-181a-5p) are also involved in cell proliferation, regulation of 
developmental processes, regulation of cell differentiation, germ cell development, and gonadal development 
(ACVR2A, CCND1, CCNE2, HMGA2, BMI1, HSP90AA1, NOTCH2, NR2C2 and BCL2).
To perform statistical analysis on the biological processes for which the target genes have differentially 
expressed miRNAs, we carried out an over-representation test calculation (PANTHER platform) that yielded 
significant values (p < 0.05) for biological processes related to development, differentiation, and processes impli-
cated in spermatogenesis (Data is shown in Figs. 3 and 4; Supplementary data tables S4 and S5). The participation 
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of target genes in these biological processes is not exclusive as significant differences were also observed in oth-
ers (for example, regulation of metabolic process (GO:0050789), regulation of gene expression (GO:0010468), 
regulation of developmental process (GO:0050793), and apoptotic process (GO:0006915)). 
Discussion
Noncoding RNAs play critical roles in the control of gene expression, and they are differentially regulated during 
 spermatogenesis21,22. The roles of miRNAs as regulatory factors that control the expression of a large number of 
protein-coding genes are well documented. miRNAs function mainly after transcription, affecting the stability 
or translational efficiency of their target  mRNAs23. Increased expression levels of miRNA genes located on the 
X chromosome may contribute to the KS phenotype. Here, miRNA expression was analysed in testicular tissue 
biopsy samples from patients with KS and control samples from patients with obstructive azoospermia with 
normal testicular tissue histology. Next-generation sequencing analysis enabled the construction of a differen-
tial expression profile. Previously, a miRNA cluster associated with Xq27 was shown to display testis-specific 
expression in healthy tissues (hsa-mir-506, hsa-mir-507, hsa-mir-508, hsa-mir-509, hsa-mir-510, hsa-mir-513, 
and hsa-mir-514)24. The expression of these miRNAs was detected in the present study in the testicular tissue 
from both experimental groups, which indicates that our approach provides reliable information regarding the 
miRNA expression profile. Interestingly, the expression levels for these specific miRNAs showed no differences 
between the normal males and KS patients.
The investigation of miRNAs revealed that a single miRNA can have multiple target mRNAs and different 
sets of miRNAs expressed in different cell types and tissues with multiple functions in the development of many 
biological processes. Abnormal miRNA expression is implicated in disease  states25. An analysis of miRNA expres-
sion profiles in testicular tissue of male patients with infertility was previously  published26,27. The first report of 
altered miRNA expression in the testes of patients with nonobstructive azoospermia was published by Lian et al., 
who showed a decrease in the expression of 154 miRNAs and a clear increase in the expression of 19  miRNAs27. 
Wu et al. evaluated the expression patterns of miR-i9B and let-7a in individuals with idiopathic infertility by 
quantitative PCR. They clearly showed that these two miRNAs were expressed at higher levels in the cases of 
infertile patients than they were in fertile  individuals28.
Table 1.  List of differentially expressed miRNAs. There were 27 miRNAs in the high-expression group that 
displayed differential expression (up/down) in the KS and control samples. From the 166 miRNAs that showed 
differential expression, we showed only those that were either highly upregulated- or downregulated and listed 
them according to significance.
miR_name Up/down log2 (fold_change) p Value (t_test)
hsa-miR-654-3p Up 1.84 8.72E−04
hsa-miR-127-3p Up 2.67 2.18E−03
hsa-let-7b-5p Up 0.78 8.25E−03
hsa-miR-199a-5p Up 1.35 1.37E−02
hsa-miR-125a-5p Up 1.27 1.76E−02
hsa-miR-125b-5p Up 0.98 1.79E−02
hsa-miR-199b-3p Up 1.03 3.78E−02
hsa-miR-106b-5p Down − 1.23 7.75E−05
hsa-miR-30a-3p Down − 1.39 9.56E−05
hsa-miR-16-5p Down − 1.29 3.62E−04
hsa-miR-30a-5p Down − 1.39 9.21E−04
hsa-miR-126-3p Down − 0.93 1.22E−03
hsa-miR-17-5p Down − 1.90 1.58E−03
hsa-miR-106a-5p Down − 1.90 1.58E−03
hsa-miR-25-3p Down − 1.16 5.13E−03
hsa-miR-30c-5p Down − 0.97 5.49E−03
hsa-let-7g-5p Down − 0.71 8.96E−03
hsa-miR-92a-3p Down − 0.62 1.01E−02
hsa-miR-15b-5p Down − 1.56 1.29E−02
hsa-miR-103a-3p Down − 0.58 1.90E−02
hsa-miR-10a-5p Down − 1.75 2.22E−02
hsa-miR-142-3p Down − 1.57 2.74E−02
hsa-miR-21-5p Down − 0.96 2.78E−02
hsa-miR-23b-3p Down − 0.99 2.85E−02
hsa-miR-148b-3p Down − 0.63 3.44E−02
hsa-miR-93-5p Down − 1.80 3.96E−02
hsa-miR-181a-5p Down − 0.78 4.01E−02
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Several miRNAs have been shown to play roles in multiple spermatogenesis stages. miRNAs follow phase-
specific expression patterns inside the testis and at distinct phases of  differentiation22. We were interested in 
analysing whether the miRNAs have a differential expression pattern among our experimental groups.
The mouse Mirlet7 miRNA plays a critical role in the proliferation and differentiation of spermatogonial cells 
through the regulation of key  genes29. Studies in a mouse Klinefelter model (41,XXY), in which the expression of 
LIN28A is low, suggested that azoospermic individuals are born with a reduced number of spermatogonia and 
consequently have a reduced number of spermatogonia throughout  life30. LIN28A is an RNA-binding protein that 
is highly expressed in pluripotent mouse embryonic stem cells and is specifically expressed in undifferentiated 
mouse  spermatogonia31. The expression of LIN28A is epigenetically regulated by the miR-125a and miR-125b. 
An increase in miR-125b resulted in the negative regulation of Lin28A mRNA. In the current study, a significant 
increase in the expression levels of hsa-mir-125b and hsa-mir-125a was observed in the KS samples compared to 
those of the control samples. The induction of let-7 by the downregulation of LIN28A inhibited the self-renewal 
capacity of non-differentiated cells and promoted their  differentiation32–34. Here, there was a significant increase 
Figure 1.  Heatmap of differentially expressed miRNAs. Heatmap depicting the differential expression 
of miRNAs in the Klinefelter and control testicular tissue samples. Twenty (20) of these miRNAs showed 
downregulated expression (red), and 7 showed upregulated expression (green) in the samples from the 
Klinefelter syndrome patients compared to the levels in the samples from the control group.
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in the expression of hsa-let-7b miRNA. There was a significant difference in hsa-let-7g expression between 
groups, but in this case, the expression was lower in the KS patient samples.
Several miRNAs have been implicated in the regulation of spermatogonial stem cells (SSCs), including miR-
21, miR-20, and miR-106a, which are preferentially expressed by  SSCs35. Interestingly, the inhibition of miR-21 
increased the number of germ cells that underwent apoptosis. In our study, we detected a decreased expression 
level of hsa-mir-21, which could have been related to the apoptosis of germ cells. Overexpression of miR-20 
and miR-106 increased the proliferation rate of  SSCs36. In our study, both of these miRNAs were expressed at a 
low level, with a significant decrease in the KS patient samples compared to their levels in the control samples.
Microarray and qPCR analyses have shown that cluster miR-449 miRNAs, miR34b, and miR-34c are pref-
erentially expressed in mouse testes, and their expression levels increase at the beginning of meiosis during 
testicular development and adult spermatogenesis. The expression pattern of the miR-449 group is similar to that 
of miRNA-34b/c during spermatogenesis, which led to the suggestion that both clusters function in a redundant 
manner in the regulation of male germ cell  development37. Our results showed a decrease in the expression levels 
of miR-34c, miR-34b, and interestingly, miR-449c and miR-449b expression was not detectable in KS patient 
samples. Decreased expression levels of miRNA-34b/c and miRNA-449 were reported for samples of infertile 
 individuals38. An analysis of the effect of both increased expression level and inhibition of miR-34c on the 
expression of Nanos2 in GC-1 cells showed that abnormal expression of miR-34c/Nanos2 interrupted the bal-
ance between autorenewal and differentiation of SSCs and ultimately led to a negative effect on spermatogenesis 
in testes with  cryptorchidism39.
Figure 2.  miRnet interactome network for the high-expression, upregulated miRNAs in the KS sample subset. 
Interaction between highly expressed upregulated miRNAs, hsa-miR-654-3p, hsa-miR-127-3p, hsa-let-7b-5p, 
hsa-miR-199a-5p, hsa-miR-125a-5p, hsa-miR-125b-5p, and hsa-miR-199b-3p (squares), in the Klinefelter 
sample tissues with target genes (blue and red dots). Blue dots represent genes involved in different cell 
functions: differentiation, cell proliferation, system development, and reproduction.
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The interactome network and miRNA target prediction analysis performed with the differentially expressed 
miRNAs found in this study showed a group of genes associated with biological processes that could be involved 
in mechanisms that affect spermatogenesis in KS patients. The results of an over-representation test showed 
significant differences in the processes of differentiation, development, and maintenance of germ cells and in 
reproductive processes, according to GO enrichment terms. Transcriptome analysis of the testicular tissue of 
a KS patient indicated a downregulated gene cluster of factors involved in spermatogenesis and male germ cell 
maturation and  morphology40. A separate transcriptional analysis of testicular tissue from KS patients with 
 hypospermatogenesis41 showed a downregulated gene cluster of factors involved in sperm production, includ-
ing EZH2. This gene has a role in the maintenance of primordial germ cells. Interestingly, our work showed 
that miR-199a-5p and let-7b-5p, which target EZH2, were upregulated in the KS patient samples, indicating a 
possible decrease in EZH2 expression.
Among other target genes of the upregulated miRNAs, the ABL1 proto-oncogene, which encodes cytoplasmic 
and nuclear protein tyrosine kinases, is implicated in cell differentiation, cell division, cell adhesion, and stress-
response  processes42. Homozygous Abl1-mutant mice had reduced viability at birth, reduced fertility, shortened 
skull, and defects in the maturation of B cells in bone  marrow43. A recent meta-analysis of gene expression profiles 
generated from testicular samples of humans with altered fertility suggested that ABL1 was among the candidate 
genes associated with arrested spermatogenesis. It is possible that the function of the gene product(s) is mediated 
by cell cycle defects, but the actual mechanism is  unknown44.
Jagged-1 (JAG1) is a ligand for the Notch receptor and its binding triggers a proteolytic excision cascade that 
eventually leads to the release of the intracellular part of the receptor from the membrane, which enables it to 
translocate to the nucleus where it activates transcription factors that play important roles in cell differentiation 
and  morphogenesis45. JAG1 is also a target gene for miR-34a and miR-21, which are also implicated in the regula-
tion of spermatogonial cell  differentiation35,46. A separate study indicated that germ cells in mouse testes induce 
the activation of Notch in Sertoli cells through Jag1 and trigger their own differentiation through the negative 
regulation of Cyp26b1. When germ cells do not produce functional Jag1, the Notch pathway is not activated, 
and the germ cells remain in an undifferentiated  state47. Interestingly, NOTCH2, a NOTCH receptor important 
during Leydig cell  differentiation48, is a target gene of some of the downregulated miRNAs (hsa-mir-16-5p, hsa-
mir-17-5p, hsa-mir-92a-3p, hsa-mir-106a-5p, hsa-mir-181a-5p, hsa-mir-15b-5p, and hsa-mir-23b-3p).
Figure 3.  Scatterplot of enriched GO terms. This graphic represents the target genes of the upregulated 
miRNAs (7) enriched in GO terms, where the colour of the circle indicates the statistical significance expressed 
in log10 values and the size of the circle the number of target genes involved.
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ERBB2 encodes an epidermal growth factor tyrosine kinase that does not have its own ligand-binding domain 
and therefore does not bind to growth factors; however, it binds strongly to other members of the EGF recep-
tor family to form heterodimers that stabilize ligand binding and increase the kinase-mediated activation of 
signalling  pathways47,49. ERBB2 and ERBB3 were detected in undifferentiated type A spermatogonia and in 
a rat spermatogonial stem cell line. The diversity of receptors and ligands in the EGF superfamily in rat testis 
cells was analysed, and evidence for the role of ERBB3 and ERBB2 in the retinoic acid-induced differentiation 
of spermatogonia was  obtained50.
Leukaemia inhibitory factor (LIF) is a pleiotropic cytokine that belongs to the interleukin 6 (IL6) family. It 
plays an important role in the balance mechanism between stem cell proliferation, and differentiation. In Sertoli 
cells, elimination of LIF receptor (LIFR) leads to a degenerative phenotype characterized by abnormal loss of 
germ cells, sperm stasis, distension, and posterior atrophy of the seminiferous  tubules51.
Some target genes of the downregulated miRNAs, such as ACVR2A, CCND1, CCNE2, HMGA2, BMI1, NR2C2 
and BCL2, have been associated with gonadal development, and germ cell maintenance through different path-
ways which could be relevant to the molecular mechanisms affected in KS patients with azoospermia. The 
ACVR2A, CCNE2, and HMGA2 genes participate in meiotic regulation during male germ cell  development52–54. 
NR2C2, a member of the nuclear hormone receptor superfamily is an important factor in normal spermatogen-
esis; NR2C2 knockout mice show defects in the late-stage pachytene and diplotene spermatocytes preventing 
progress and completion of the meiotic  divisions55. BMI1 plays important roles in maintaining germ stem cells 
and in regenerating spermatogenic progenitors after  injury56.
It has been shown that Bcl-2 inhibits apoptosis of spermatogonia and the growth of spermatogonial stem 
cells in a cell-intrinsic  manner57. The Bcl-2 family of genes encodes a family of closely-related proteins that 
Figure 4.  Scatterplot of enriched GO terms. This graphic represents the target genes of the downregulated 
miRNAs (20) enriched in GO terms, where the colour of the circle indicates the statistical significance expressed 
in log10 values and the size of the circle the number of target genes involved.
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possess either proapoptotic or antiapoptotic  activity58. Interestingly, BCL2 is a target for one of the miRNAs that 
are downregulated in KS patients, thus it could be the testicular germ cell loss may be related to misregulation 
of BCL2.
Evidence of the function of these genes in spermatogenesis and development, as well as their participation in 
the differentiation of spermatogonia, may explain how alterations to the proliferation mechanisms of SSCs inhibit 
the maintenance and survival of undifferentiated spermatogonial cells and thus abrogate spermatogenesis in the 
long term. Our results are consistent with evidence showing their role in oligozoospermia in KS, but further 
studies are necessary to assess the role(s) of these miRNA-based mechanisms in the reproductive phenotype of 
Klinefelter patients.
This is the first report of a miRNA expression profile based on testicular tissue from patients with Klinefelter 
syndrome. We identified 166 miRNAs that were differentially expressed. Of these, 27 were particularly abundant: 
20 downregulated and 7 upregulated in samples derived of the KS patients compared to normal controls. These 
miRNAs have target genes that are related to spermatogenesis, which could inform future approaches to the 
evaluation of the mechanisms involved in the infertility of Klinefelter syndrome patients.
Materials and methods
Study design. A descriptive, transversal, comparative, case–control study was designed to analyse the 
expression profile of miRNAs in the testicular tissue of patients with Klinefelter syndrome and to compare it to 
the profile obtained for the normal testicular tissue. This study was approved by the Ethics Committee of School 
of Medicine, Universidad Autónoma de Nuevo León. Informed consent was obtained for donating the tissues to 
the biobank, and all the samples and information accessed by the authors were fully anonymized. All methods 
were performed in accordance with the relevant guidelines and regulations.
Sample collection. Paraffin-embedded samples of testicular tissue from KS patients (cases) and subjects 
with obstructive azoospermia (controls) were obtained from the Department of Pathology Anatomy of the Uni-
versity Hospital La Paz (Madrid, Spain). In general, a G band karyotype (50 metaphases) was obtained to con-
firm the characterizations of the KS and normal chromosome sets. Additionally, a histopathological examination 
was performed to analyse the presence or absence of germ cells.
Three KS patients had a karyotype formula of 47,XXY, and one patient had a mosaic formula (47,XXY/46,XY). 
Patient ages were in the range of 33–36 years, and control individuals in the 30–40-year range. For three (3) 
patients, two samples (one from each testis) were obtained and labelled as KLI_1 to KLI_6; the fourth patient had 
only one sample available (KLI_7). All the samples showed seminiferous tubules with spermatogenesis (1–5%), 
sclerosis (75–90%), and Sertoli cells-only (10–25%). Histological characteristics of the samples are detailed in 
Supplementary data Table S6.
All control samples were derived from biopsies of patients with infertility because of azoospermia with an age 
range of 30–40 years. In these samples, the seminiferous tubules had complete spermatogenesis with changes that 
suggested the presence of obstruction like tubular ectasia, seminiferous epithelium irregular in height, vacuoliza-
tion of the apical pole of Sertoli cells and a higher number of adult spermatids than young spermatids per cross 
tubular section. These observations and the normal spermatogonia counts led to the diagnosis of obstructive 
azoospermia. No seminiferous tubules with Sertoli cells-only or with sclerosis were observed. All of the controls 
had a 46,XY karyotype. Each sample was processed and analysed separately (i.e., no pooled samples). For each 
sample, from five to ten paraffin 15-micron sections were cut with a microtome, placed in Eppendorf tubes, and 
labelled with a numeric key.
Extraction of total RNA. Total RNA extraction was performed with a mirVana™ miRNA isolation kit (Life 
Technologies, Grand Island, NY) from the paraffin sections as instructed by the vendor. The purity of the RNA 
samples were measured with an Agilent 2,100 Bioanalyzer and the Agilent RNA 6,000 Pico Kit (Agilent, CA, 
USA). The samples used for analyses contained at least 50 nanograms of total RNA with, at least, a 1.8 absorb-
ance ratio (260/280 nm).
Sample analysis. Library construction and sequencing. Approximately 1 µg of total RNA was used to pre-
pare a small RNA library according to the instructions in the TruSeq small RNA Sample preparation kit (Illumi-
na, San Diego, USA). Single-end sequencing of 50 bp was performed on an Illumina HiSeq 2,500 (Illumina, San 
Diego, USA). The raw sequence data is available at https ://www.ncbi.nlm.nih.gov/biopr oject / PRJNA640051, 
BioProject: PRJNA640051, ID: 640,051.
Bioinformatics analysis. Raw reads were processed with ACGT101-miR (LC Sciences, Houston, Texas, USA) to 
remove adapter dimers, junk, low complexity reads, common RNA families (rRNA, tRNA, snRNA, and snoRNA) 
and repeats. Subsequently, unique sequences with lengths of 18–26 nucleotides were mapped to specific-species 
precursors obtained from the miRBase 22.0 by a BLAST search performed to identify known miRNAs and novel 
3p- and 5p-derived miRNAs. The remaining sequences were aligned against the miRbase (Release 21) (https ://
www.miRba se.org/) miRNA database, and perfectly matched sequences were considered to be conserved Homo 
sapiens miRNAs.
The normalization of the sequence counts in each sample (or data set) was achieved by dividing the counts 
by a library size parameter of the corresponding sample. The library size parameter was the median value of the 
ratio of the counts in a specific sample to those in a pseudo-reference sample. The count number in a pseudo-
reference sample is the geometric mean of the counts across all samples. The expression level for each miRNA was 
categorized in 3 groups: high (a sequence count higher than the average copy number in the data set), medium 
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(a sequence count higher than 10 and less than the average copy number in the data set), and low (a sequence 
count lower than 10).
Statistical analysis. Differential expression of miRNAs as a function of normalized deep sequence count-
ing was analysed through the selective use of Student’s t-tests. The significance threshold was set at < 0.05 for each 
test. Paired samples from 3 patients (KLI_1 to KLI_6) were used to increase reproducibility. Patient number 4 
had only one biopsy sample, and thus, there was no paired sample available, and this single sample was included 
to increase the statistical strength of our study.
miRNAs—target prediction and interaction networks. We carried out two separate interactome analyses of dif-
ferentially and highly expressed miRNAs, one for the upregulated and another for the downregulated using the 
miRNet database  platform19,20. This database integrates the information from 11 different miRNA databases: 
TarBase, miRTarBase, miRecords, miRanda, miR2Disease, HMDD, PhenomiR, SM2miR, Pharmaco-miR, Epi-
miR, and StarBase. The miRNA target prediction was followed by an interactome network analysis and a GO 
term enrichment for terms related to sex differentiation, male sex reproduction, and cell differentiation and 
development. The miRNA-predicted target genes were visualized with Cytoscape software (https ://cytos cape.
org/). Cytoscape is an open source software package that allows for powerful visual mappings of the provided 
datasets.
The target genes obtained were analysed through a statistical analysis of the over-representation test results 
using the PANTHER  platform59. For P-value calculation for the over-representation test data, the ‘expected’ value 
is the number of genes expected to be added to the test list for a particular PANTHER category (GO biological 
process), based on a predetermined reference list. The list of target genes for the differentially overexpressed 
miRNAs was used to calculate the p-value with Fisher test with a significance value of p < 0.05.
Data availability
The datasets generated and/or analysed during the current study are available in the Sequence Read Archive 
(SRA) repository, https ://www.ncbi.nlm.nih.gov/biopr oject /PRJNA 64005 1, BioProject: PRJNA640051, ID: 
640,051.
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